Madras High Court on Tuesday directed a committee, set up by the Tamil Nadu government to consider representations by medical practitioners to prevent or treat coronavirus through alternative medicines.
A division bench of Justice Vineet Kothari and Justice R Suresh Kumar heard the matter through video conferencing and slated it for further hearing after four weeks or after the court resumes regular working following the relaxation of the lockdown.
"In view of the technical committee already having been constituted for this purpose during the present times of COVID 19 or coronavirus spreading the world over, we direct the said committee to consider all the concerning representations made in this regard to the State government, for prevention and treatment of the said disease," the court said.
The High Court said that it hopes and expects that the said committee and the state government will take appropriate decision in this matter as quickly as possible so that the public at large can immediately avail the benefit of the same.
The court was hearing a petition filed by K Muthu Kumar Nayakar and Dr KM Senthamizh Selvan, members of the Ayush Medical Welfare Association.
The plea sought directions to the state government to constitute a committee to consider the representations to allow medical practitioners to provide relief to coronavirus affected people and others, as preventive measures or treatment in the form of alternative medicines by way of Ayurvedha, Siddha, Unani, Homeopathy or Naturopathy methods, besides Allopathy.
Additional Advocate General Arvind Pandian, representing the state government, submitted that the state government has already constituted a technical committee comprising of the experts in various fields, who will consider all such representations in this regard.
Pandian said that the committee will also issue appropriate guidelines for practitioners of the respective fields and also for common public members and under which, such guidelines can be followed by the persons concerned.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
